Commonwealth Equity Services, LLC Ab Cellera Biologics Inc. Transaction History

Commonwealth Equity Services, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 23, 2023	BUY	$4.6 - $7.95 $4,600 - $7,950	1,000 Added 9.08%	12,019 $55,000
Q2 2023 Aug 10, 2023	SELL	$5.66 - $7.59 $1,403 - $1,882	-248 Reduced 2.2%	11,019 $71,000
Q1 2023 May 11, 2023	BUY	$7.31 - $11.18 $5,277 - $8,071	722 Added 6.85%	11,267 $84,000
Q4 2022 Feb 07, 2023	SELL	$9.48 - $14.52 $24,648 - $37,752	-2,600 Reduced 19.78%	10,545 $106,000
Q3 2022 Nov 14, 2022	SELL	$9.2 - $13.68 $17,599 - $26,169	-1,913 Reduced 12.7%	13,145 $130,000
Q2 2022 Jul 19, 2022	SELL	$5.72 - $10.65 $2,751 - $5,122	-481 Reduced 3.1%	15,058 $160,000
Q1 2022 May 04, 2022	SELL	$7.46 - $14.14 $2,208 - $4,185	-296 Reduced 1.87%	15,539 $151,000
Q4 2021 Jan 31, 2022	SELL	$12.99 - $17.73 $49,219 - $67,178	-3,789 Reduced 19.31%	15,835 $226,000
Q3 2021 Oct 29, 2021	BUY	$14.85 - $21.34 $291,416 - $418,776	19,624 New	19,624 $393,000

153

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $787M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.